Point of Care For Sepsis Diagnostics Market Size (2024 – 2030)

The Point of Care for Sepsis Diagnostics Market was valued at USD 516.62 million and is projected to reach a market size of USD 1001.64 million by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 9.92%.

In the past there was limited availability for testing sepsis, most of them required traditional laboratory testing, which not only consumed a lot of time but also resulted in human errors. However, with the advancement in testing technologies, detecting sepsis became easy and increased consumer demand for POCT diagnostics for sepsis. These included advanced biomarker testing devices or tools, at-home testing kits, and AI-enabled point-of-care devices for analyzing and monitoring patients. Furthermore, compact POCT devices provided convenience and rapid results to both homecare patients and hospitals, resulting in increased efficiency in treatments. Furthermore, the future holds positive for the point of care for the sepsis diagnostics market, as AI is increasingly adopted in hospitals and clinics for testing, analyzing, and monitoring purposes. Moreover, advancements in nanotechnology have led to the development of miniature and handheld POCT devices that can enable quick and early detection of sepsis at the molecular level.

Key Market Insights:

As per WHO, nearly 85% of sepsis cases, including death cases occur in low-resource settings,

Moreover, children account for 49 million cases of sepsis every year.

Furthermore, 27% of people suffering from sepsis were in hospitals in 2022 and 42% of people died in intensive care units (WHO)

As per research published by the National Institute of Health (PubMed), 60% of sepsis cases occur in patients aged 65 years and above.

Point of Care For Sepsis Diagnostics Market Drivers:

Increasing cases of sepsis have boosted the demand for point-of-care sepsis diagnostics in the market.

The increasing incidence of sepsis is the major factor contributing to the demand for POC diagnostics. Sepsis is an infectious disease that damages the immunity system, and in chronic cases can lead to organ failure. Moreover, the disease is more prone to the elderly, as they are at higher risk of developing chronic diseases due to reduced functioning of the body and weak immunity system. Therefore, POC diagnostics devices can help in early detection of sepsis and prevent patients from fatalities such as organ failure, or in severe cases of death. Moreover, as per WHO, sepsis kills 11 million every year, of which children account for the most cases of sepsis Furthermore, biomarker and diagnostic marker tests are at the forefront in diagnosing the severity of sepsis and analyzing the pathogen that helps in developing a targeted treatment for it. Moreover, the compact and portable structure of POC diagnostics devices enables testing even at remote places, in ambulances, emergency and intensive care units, and others.

The rising geriatric population has boosted the demand for point-of-care for sepsis diagnostics in the market.

The rapidly aging population is the major reason for the increase in the number of sepsis, as aged people have weak immune systems, which becomes a prime cause of chronic diseases, such as sepsis. Moreover, aged people already suffering from other illnesses such as diabetes, are at high risk of developing sepsis. Therefore, there is an increase in demand for POC diagnostics devices that detect sepsis for immediate treatment procedures. Most common among these testing requirements are homecare testing kits such as bedside testing, which allow caregivers or family members of the elderly to analyze and monitor the severity of sepsis and seek immediate treatment from doctors.

Point of Care For Sepsis Diagnostics Market Restraints and Challenges:

Data privacy issues in smart POCT diagnostics can decline its demand in the market. Smart POCT devices contain patients’ data on online software, which is exposed to cyber threats such as data leaks, misuse of data, or privacy leaks, resulting in reduced safety of patients.

Some POCT devices, especially at-home care devices with complex structures and functioning can be difficult to handle, resulting in inaccurate or faulty results. This can decline the demand for point-of-care for sepsis diagnostics in the market.

Point of Care For Sepsis Diagnostics Market Opportunities:

The Point of Care For Sepsis Diagnostics Market is anticipated to deliver lucrative opportunities for businesses, which include acquisitions, partnerships, collaborations, product launches, and agreements during the forecasted period. Furthermore, the growing prevalence of sepsis, especially among the elderly and children, and rising demand for on-site and convenient diagnosis is predicted to develop the market for the point of care for sepsis diagnostics and enhance its future growth opportunities.

POINT OF CARE FOR SEPSIS DIAGNOSTICS MARKET REPORT COVERAGE:

Point of Care For Sepsis Diagnostics Market Segmentation: By Diagnostic Method

• Biomarker Test

• Molecular Diagnostics

• Immunoassays

• Others

In 2022, based on market segmentation by diagnostic method, biomarker tests occupied the highest share of about 25.5% in the market. Biomarker tests for sepsis include measuring specific markers in the patient’s blood and then analyzing the presence of sepsis. Moreover, the most commonly used biomarkers are procalcitonin, C-reactive protein, cytokines, and others. Furthermore, the growth of this segment is attributed to increased efficiency and rapid delivery of results that help in devising treatment solutions for sepsis and analyzing patient’s responses to these solutions.

Molecular diagnostics is the fastest-growing segment during the forecast period. Molecular diagnostics helps in detecting pathogens causing sepsis in the patient’s body through genetic diagnosing. This method usually involves DNA or RNA sequencing for understanding the presence of pathogens and devising treatment procedures based on the results obtained. Moreover, the technique helps in delivering faster results by analyzing blood samples, urine, cerebrospinal fluid, and others. Furthermore, these can use portable or compact devices such as blood analyzers, and others.

Point of Care For Sepsis Diagnostics Market Segmentation: By End-User

• Hospitals & Clinics

• Homecare

• Research Laboratories

• Others

In 2022, based on market segmentation by end-users, hospitals & and clinics occupied the highest share of about 32% in the market. Hospitals & clinics are major users for diagnosing onsite sepsis using various devices, that provide immediate testing and diagnosing of sepsis patients. Moreover, this enables healthcare professionals to perform immediate treatment based on the results obtained. Additionally, many hospitals use POC monitoring devices that monitor patient’s progress and response to specific treatments or drugs, thereby assisting doctors in devising immediate interventions in emergency cases.

The homecare segment is the fastest-growing segment during the forecast period. Post-pandemic, there is an increasing trend in homecare testing and monitoring, which has increased the demand for POC homecare diagnostic devices for sepsis that enable individuals to perform tests that can detect early signs of infections. Moreover, POC diagnostic devices equipped with telemonitoring and teleconsultation services enable individuals to share their reports with doctors for further treatment procedures. In addition, these devices allow mobile app integration that allows medical professionals to remotely monitor patient’s health, including geriatric patients that are more exposed to diseases such as sepsis.

Point of Care For Sepsis Diagnostics Market Segmentation: By Pathogen

• Bacteria

• Fungal

• Viral

In 2022, based on market segmentation by pathogen, bacteria occupied the highest share of about 30% in the market. Bacteria sepsis diagnostics focuses on diagnosing the presence of common bacteria found in sepsis such as staphylococcus aureus, E. coli, Klebsiella pneumoniae, and others. Moreover, devices used for testing bacteria involve using blood culture systems, molecular diagnostic devices, rapid testing tools, sensitivity testing, and others.

The viral segment is the fastest-growing during the forecast period. These include performing diagnosis for analyzing the virus severity in sepsis, such as viruses that can directly or indirectly lead to sepsis (adenoviruses, influenza viruses, herpes simplex virus, and others). Furthermore, common diagnostic techniques used are collecting DNA or RNA samples of patients for performing nucleic acid testing, biomarker/diagnostic marker testing, serological testing, and others.

Point of Care For Sepsis Diagnostics Market Segmentation: By Age

• Pediatric

• Adult

• Geriatric

In 2022, based on market segmentation by age, geriatric occupied the highest share of about 36% in the market. Sepsis has been diagnosed as a disease of the elderly since they are more prone to medical conditions that lead to sepsis. These include respiratory conditions, diabetes, obesity, immunodeficiency viruses, and others. Furthermore, as per research published by the National Health Institute (PubMed), sepsis-related mortality accounted for 80% of patients aged 80 years. This has further raised the demand for POC diagnostics that enable family members of the elderly to perform at-home tests and remotely monitor their health them.

Pediatric is the fastest-growing segment during the forecast period. Children too, especially kids aged below 14, and infants develop sepsis due to an injury, inflammation, infection, or an already existing disease, which is left untreated. POC diagnostics help in early detection of sepsis in children and minimize the risk of future damage helping healthcare professionals in devising preventive treatment procedures.

Point of Care For Sepsis Diagnostics Market Segmentation: Regional Analysis

• North America

• Europe

• Asia-Pacific

• South America

• Middle-East & Africa

In 2022, based on market segmentation by region, North America occupied the highest share of about 38% in the market. The presence of technologically advanced diagnostic devices along with robust healthcare infrastructure has contributed to the demand for point-of-care for sepsis diagnostics in the region.

Asia-Pacific is the fastest-growing region during the forecast period. Increasing demand for on-site diagnosis in hospitals and clinics, growing trends in telehealth and telemedicine, and increasing government support for the healthcare sector in the form of grants and investment expenditure have contributed to the demand for point-of-care for sepsis diagnostics in the region.

COVID-19 Impact Analysis on the Point of Care For Sepsis Diagnostics Market:

The pandemic had a significant impact on the point of care for the sepsis diagnostics market. The market witnessed increased demand for POC diagnostics for detecting diseases due to the risks posed by the virus outbreak. Sepsis being an infectious disease, witnessed an increased amount of testing requirements by hospitals and healthcare units, as the virus outbreak resulted in further damage to the body, and sepsis is one of them. However, the shortage of healthcare services and shifted focus towards treating virus-infected patients during the pandemic resulted in declined demand for POCT for sepsis diagnostics in the market. However, increased digitization during the pandemic helped the healthcare sector overcome the disadvantage caused by to shortage of healthcare services by adopting telehealth and telemedicine services, which helped to bring down the delay in treating patients during the pandemic.

Latest Developments:

The market for point of care for sepsis diagnostics is witnessing increased demand due to constant product innovations, rising consumer demand for early detection and rapid delivery testing devices; and rising trends in telehealth in the market.

In November 2022, Immunexpress launched a rapid testing device for sepsis called – SepiCyte Rapid. The products test sepsis directly from the blood draw in a day, thus facilitating fast diagnosis of sepsis. Moreover, the product uses PCR technology to detect mRNA signatures in the blood sample and evaluate the severity of bacteria or other pathogens causing the infection.

Key Players:

1. Siemens

2. Abbott

3. AdvanDx

4. Miacom Diagnostics

5. Biofire Diagnostics

6. Alteco Medical

7. Becton Dickinson

8. Wolters Kluwer

9. Immunexpress

10. Inflammatix

11. Mbio

12. Abionic